
stocks · Tuesday, June 2, 2026 · 3 min
Don't chase Similarweb at $4.57: a director just paid $3.77, wait for the pullback
Similarweb measures who uses ChatGPT, Claude and Gemini, the same apps sitting at the top of the US App Store today. A director bought over a million dollars of stock at $3.77 yesterday and the price jumped 14.82% to $4.57 today. Buying after the jump is paying up; wait for it to settle back near $4.00.
Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.
Watch $4.00: buy zone just above the director's $3.77 purchase price1 from June 1
Watch $3.50: invalidation level; below the insider's basis means the buy was not the bottom and the thesis is wrong
Why this size: Stand-aside post. Buying SMWB today means paying 21% more than the insider paid yesterday for the same shares. Wait for a pullback into the $3.95 to $4.10 zone, then we will write a separate buy post sized at 2% of account (small-cap volatility cap).
When you'd hold this: 2 to 6 weeks, around no scheduled earnings in the next 30 days; watch for follow-on insider filings
A director of Similarweb, the company that sells data on which apps and websites people actually use, bought just over a million dollars of his own stock yesterday at $3.77 a share. The filing hit the wire this morning and the price jumped 14.82% to $4.57 in the first hour of trading. The buy is a real signal, but chasing the jump means paying 21% more than the insider paid one day ago. Wait for the price to settle back near $4.00 before buying.
What just happened
A Similarweb board director, Erez Naveh, filed a Form 4 with regulators showing he bought 271,105 shares at an average price of $3.77 on Sunday June 11. The total purchase was $1,020,716 in cash. Insiders only have to file these documents within two business days of buying, and the filing hit public databases at 7:46 AM Eastern this morning.
The market reacted fast. The stock opened around $4.00 and traded as high as $4.625 within minutes, settling at $4.57 by mid-morning. That is a 14.82% jump from yesterday's close of $3.98.
The context here matters. Similarweb's product is digital traffic measurement: it tells companies how many people visit a website, which app they switched to afterwards, how long they stayed. The five most-downloaded productivity apps in the US App Store today are ChatGPT (#1), Claude (#3), Google Gemini (#4) and Threads (#5)4. Three of those five are AI chatbots. Companies running marketing budgets for AI tools need third-party traffic data to know which assistant is winning, and Similarweb is one of the few public companies that sells exactly that.
So what
A director buying a million dollars of his own stock at a fresh low is the strongest insider signal there is. He cannot sell for six months without filing again, so he is committing real money to a slow move.
The AI app boom creates a real customer base for what Similarweb sells. Every company building or competing with ChatGPT wants to know how much traffic Claude or Gemini is pulling, and a research subscription from Similarweb is how they find out.
But the price already jumped 14.82% before most retail traders saw the news. Buying now means starting the trade 21% above the insider's basis, which means his protection (the floor where he is likely to buy more) is much further below than the protection of someone who bought at $3.77.
Which is why the right move is patience. The insider's $3.77 is the real floor. If the stock drifts back near $4.00 in the next two weeks (small caps almost always give back half of a one-day jump), that is the entry. If it never pulls back, we miss this one and that is fine.
What to do about it
Do not buy Similarweb today at $4.57. Set a price alert at $4.00. If the stock pulls back into the $3.95 to $4.10 zone in the next two to four weeks, that is where to start a small position (no more than 2% of your account, this is a $4 small-cap stock and they move violently).
If the stock instead falls below $3.50 (under the insider's basis), the signal failed and we walk away.
The risk: small caps that pop on insider filings sometimes never come back, especially if a second insider files the same week or a research firm picks it up. Missing the trade is the cost of not chasing it.
What we got right (and wrong) before
Two posts ago we said buy RLI at $49.68 on a similar insurance-insider cluster buy. RLI is at $52.06 today, up 4.8%, with the open position working. Same playbook here, except RLI did not have a 14.82% same-day jump to chase through. Patience paid there and it should pay here.
For the nerds
SMWB: spot $4.57, +14.82% on the day, RSI 77.15 (overbought, approaching extreme), MACD bullish crossover with histogram 0.087, 50-day moving average $3.04, 200-day $6.05. The stock is still in a longer-term downtrend (50 below 200) but the short-term momentum has flipped positive. 52-week range $2.22 to $10.75.
Insider trade: Erez Naveh, director, Form 4 filed 2026-06-02 07:46 ET, 271,105 shares purchased 2026-06-01 at $3.77 average, post-trade ownership 15,795,073 shares (+2%)1. This is a non-10b5-1 open-market purchase, the highest-signal kind.
For context on the AI-app angle: ChatGPT, Claude and Google Gemini together occupy three of the top five free productivity slots in the US App Store as of today's snapshot4. Similarweb's enterprise dashboard sells exactly the traffic-comparison data these companies' rivals need to benchmark.
Not financial advice. Do your own research.
What we passed on
- $Matador Resources (MTDR)PENDING
Another oil insider bought, but we already published two energy posts this week. Skipping to keep coverage varied.
- $Goosehead Insurance (GSHD)PENDING
Insurance insider cluster buy at $37.392, but we just published a buy on insurer RLI two posts ago. Same theme, skipping.
- $Ascendis Pharma (ASND)PENDING
Director bought at $228.273, stock dropped 8.7% to $218.82 today on no fresh news; setup is interesting but we want to see why it fell before stepping in.